Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | SCN1A | P35498 | 1/20 | 0.30 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.30 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethenamid SCHEMBL53864 | 1.00 | THRB (1.00) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| Dimethenamid SCHEMBL18223 | 1.00 | THRB (1.00) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| Dimethenamid SCHEMBL20723471 | 0.99 | THRB (0.97) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| Dimethenamid SCHEMBL20723446 | 0.99 | THRB (0.97) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| Dimethenamid SCHEMBL28212854 | 0.94 | THRB (0.88) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| Dimethenamid SCHEMBL18115255 | 0.89 | THRB (0.79) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| SCHEMBL8438401 | 0.88 | THRB (0.79) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| Metolachor SCHEMBL17927060 | 0.88 | THRB (0.78) | THRBALDH1A1SMN1; SMN2TP53LMNA | |
| SCHEMBL20611099 | 0.88 | THRB (0.79) | THRBALDH1A1SMN1; SMN2LMNAMEN1 | |
| Diphenamide SCHEMBL2314459 | 0.85 | THRB (0.73) | THRBALDH1A1SMN1; SMN2TP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637354-A1 | HERBICIDAL COMPOSITION WITH BUILT-IN ADJUVANT | BASF SE (DE) | 2025-10-29 | — | — | EP | disclosed |
| EP-3160230-B1 | FORMULATION OF CLOMAZONE HAVING REDUCED VOLATILITY | BASF SE (DE) | 2023-11-01 | — | — | EP | disclosed |
| CN-116887675-A | Herbicidal compositions comprising imidazolinone-based acetolactate synthase inhibitors and uses thereof | 安道麦阿甘有限公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20170127677-A1 | Formulation of clomazone having reduced volatility | BASF SE (DE) | 2017-05-11 | — | — | US | disclosed |
| WO-2008008754-A2 | HERBICIDAL COMPOSITION | FMC CORPORATION (US) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170127677-A1 | Formulation of clomazone having reduced volatility | CYP51A1, CYP2C8, SYMPK | THRB 2738/4885ALDH1A1 1172/4885SMN1; SMN2 4171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.